378 related articles for article (PubMed ID: 12446059)
1. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy.
Sabatine MS; Morrow DA; Cannon CP; Murphy SA; Demopoulos LA; DiBattiste PM; McCabe CH; Braunwald E; Gibson CM
J Am Coll Cardiol; 2002 Nov; 40(10):1761-8. PubMed ID: 12446059
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.
Wiviott SD; Cannon CP; Morrow DA; Murphy SA; Gibson CM; McCabe CH; Sabatine MS; Rifai N; Giugliano RP; DiBattiste PM; Demopoulos LA; Antman EM; Braunwald E
Circulation; 2004 Feb; 109(5):580-6. PubMed ID: 14769678
[TBL] [Abstract][Full Text] [Related]
3. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
4. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction.
Cannon CP; Weintraub WS; Demopoulos LA; Robertson DH; Gormley GJ; Braunwald E
Am J Cardiol; 1998 Sep; 82(6):731-6. PubMed ID: 9761082
[TBL] [Abstract][Full Text] [Related]
5. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction.
Wong GC; Morrow DA; Murphy S; Kraimer N; Pai R; James D; Robertson DH; Demopoulos LA; DiBattiste P; Cannon CP; Gibson CM
Circulation; 2002 Jul; 106(2):202-7. PubMed ID: 12105159
[TBL] [Abstract][Full Text] [Related]
6. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy.
Barron HV; Cannon CP; Murphy SA; Braunwald E; Gibson CM
Circulation; 2000 Nov; 102(19):2329-34. PubMed ID: 11067784
[TBL] [Abstract][Full Text] [Related]
7. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Sadanandan S; Cannon CP; Chekuri K; Murphy SA; Dibattiste PM; Morrow DA; de Lemos JA; Braunwald E; Gibson CM
J Am Coll Cardiol; 2004 Aug; 44(3):564-8. PubMed ID: 15358021
[TBL] [Abstract][Full Text] [Related]
8. Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial.
Weintraub WS; Culler SD; Kosinski A; Becker ER; Mahoney E; Burnette J; Spertus JA; Feeny D; Cohen DJ; Krumholz H; Ellis SG; Demopoulos L; Robertson D; Boccuzzi SJ; Barr E; Cannon CP
Am J Cardiol; 1999 Feb; 83(3):317-22. PubMed ID: 10072215
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies.
de Lemos JA; Morrow DA; Gibson CM; Murphy SA; Sabatine MS; Rifai N; McCabe CH; Antman EM; Cannon CP; Braunwald E
J Am Coll Cardiol; 2002 Jul; 40(2):238-44. PubMed ID: 12106926
[TBL] [Abstract][Full Text] [Related]
10. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.
Mahoney EM; Jurkovitz CT; Chu H; Becker ER; Culler S; Kosinski AS; Robertson DH; Alexander C; Nag S; Cook JR; Demopoulos LA; DiBattiste PM; Cannon CP; Weintraub WS;
JAMA; 2002 Oct; 288(15):1851-8. PubMed ID: 12377083
[TBL] [Abstract][Full Text] [Related]
11. Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction.
Popma JJ; Suk J
Am J Cardiol; 2001 Oct; 88(8A):25K-29K. PubMed ID: 11694216
[TBL] [Abstract][Full Text] [Related]
12. Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.
Gogo PB; Schneider DJ; Terrien EF; Watkins MW; Sobel BE; Dauerman HL
Am J Cardiol; 2005 Aug; 96(4):538-42. PubMed ID: 16098308
[TBL] [Abstract][Full Text] [Related]
13. Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial).
Alkhalfan F; Nafee T; Yee MK; Chi G; Kalayci A; Plotnikov A; Braunwald E; Gibson CM
Am J Cardiol; 2020 Mar; 125(5):661-669. PubMed ID: 31898965
[TBL] [Abstract][Full Text] [Related]
14. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18.
Wylie JV; Murphy SA; Morrow DA; de Lemos JA; Antman EM; Cannon CP
Am Heart J; 2004 Jul; 148(1):173-80. PubMed ID: 15215808
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy.
Dokainish H; Pillai M; Murphy SA; DiBattiste PM; Schweiger MJ; Lotfi A; Morrow DA; Cannon CP; Braunwald E; Lakkis N;
J Am Coll Cardiol; 2005 Jan; 45(1):19-24. PubMed ID: 15629367
[TBL] [Abstract][Full Text] [Related]
16. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty.
Uyarel H; Uzunlar B; Unal Dayi S; Tartan Z; Samur H; Kasikcioglu H; Akgul O; Simsek D; Erdem I; Okmen E; Cam N
Cardiology; 2006; 105(3):168-75. PubMed ID: 16479104
[TBL] [Abstract][Full Text] [Related]
17. Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial.
Cannon CP
J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):43S-48S. PubMed ID: 12644340
[TBL] [Abstract][Full Text] [Related]
18. A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Sadanandan S; Cannon CP; Gibson CM; Murphy SA; DiBattiste PM; Braunwald E;
J Am Coll Cardiol; 2004 Aug; 44(4):799-803. PubMed ID: 15312862
[TBL] [Abstract][Full Text] [Related]
19. Multiple inflammatory prognostic factors in acute coronary syndromes: a prospective inception cohort study.
Hatmi ZN; Saeid AK; Broumand MA; Khoshkar SN; Danesh ZF
Acta Med Iran; 2010; 48(1):51-7. PubMed ID: 21137670
[TBL] [Abstract][Full Text] [Related]
20. White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary percutaneous coronary intervention (ANIN Myocardial Infarction Registry).
Kruk M; Karcz M; Przyłuski J; Bekta P; Kepka C; Kalińczuk Ł; Pregowski J; Kaczmarska E; Demkow M; Chmielak Z; Witkowski A; Ruzyłło W
Int J Cardiol; 2007 Apr; 116(3):376-82. PubMed ID: 16884793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
